The gold nanoparticle size and exposure duration effect on the liver and kidney function of rats: In vivo

Saudi Journal of Biological Sciences

Volumn 20, Issue 2, 2013, Pages 177-181

  Abdelhalim, Mohamed Anwar K ^a   Abdelmottaleb Moussa, Sherif A ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b AL IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY IMSIU   (Saudi Arabia)

Author keywords

Exposure duration; Gold nanoparticle; Liver and kidney function; Rats; Sizes

Indexed keywords

ANIMALIA; RATTUS;

EID: 84876103167     PISSN: 1319562X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sjbs.2013.01.007     Document Type: Article

References (21)

1. Abdelhalim M.A.K., Jarrar B.M. Gold nanoparticles administration induced prominent inflammatory, central vein intima disruption, fatty change and Kupffer cells hyperplasia. Lipids in Health and Disease 2011, 10:133.
2. Abdelhalim M.A.K., Jarrar B.M. Gold nanoparticles induced cloudy swelling to hydropic degeneration, cytoplasmic hyaline vacuolation, polymorphism, binucleation, karyopyknosis, karyolysis, karyorrhexis and necrosis in the liver. Lipids in Health and Disease 2011, 10:166.
3. Abdelhalim M.A.K., Jarrar B.M. Renal tissue alterations were size-dependent with smaller ones induced more effects and related with time exposure of gold nanoparticles. Lipids in Health and Disease 2011, 10:163.
4. Abdelhalim M.A.K., Jarrar B.M. The appearance of renal cells cytoplasmic degeneration and nuclear destruction might be an indication of GNPs toxicity. Lipids in Health and Disease 2011, 10:147.
5. Abdelhalim M.A.K. Exposure to gold nanoparticles produces cardiac tissue damage that depends on the size and duration of exposure. Lipids in Health and Disease 2011, 10:205.
6. Abdelhalim M.A.K. Exposure to gold nanoparticles produces pneumonia, fibrosis, chronic inflammatory cell infiltrates, congested and dilated blood vessels, and hemosiderin granule and emphysema foci. Journal of Cancer Science & Therapy 2012, 4(3):46-50.
7. Abdelhalim M.A.K. Gold nanoparticles administration induces disarray of heart muscle, hemorrhagic, chronic inflammatory cells infiltrated by small lymphocytes, cytoplasmic vacuolization and congested and dilated blood vessels. Lipids in Health and Disease 2011, 10:233.
8. Abdelhalim M.A.K. Optimizing a novel method for synthesizing gold nanoparticles: biophysical studies. Journal of Cancer Science & Therapy (Letter of Acceptance May 2 2012).
9. BarathManiKanth S., Kalishwaralal K., Sriram M., Pandian S.R.K., Youn H., Eom S., Gurunathan S. Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. Journal of Nanobiotechnology 2010, 8:16.
10. Chithrani B.D., Chan W.C. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Letters 2007, 7:1542-1550.
11. Gibson J.D., Khanal B.P., Zubarev E.R. Paclitaxel-functionalized gold nanoparticles. Journal of American Chemical Society 2007, 129:11653-11661.
12. Hillyer J.F., Albrecht R.M. Correlative instrumental neutron activation analysis, light microscopy, transmission electron microscopy, and X-ray microanalysis for qualitative and quantitative detection of colloidal gold spheres in biological specimens. Microscopy and Microanalysis 1999, 4:481-490.
13. Lanone S., Boczkowski J. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Current Molecular Medicine 2006, 6:651-663.
14. Lasagna-Reeves C., Gonzalez-Romero D., Barria M.A., Olmedo I., Clos A., Ramanujam V.M.S.A., Urayama A., Vergara L., Kogan M.J., Soto C. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochemical and Biophysical Research Communications 2010, 393:649-655.
15. Niidome T., Yamagata M., Okamoto Y., Akiyama Y., Takahishi H., Kawano T., et al. PEG-modified gold nanorods with a stealth character for in vivo application. Journal of Control Release 2006, 114:343-347.
16. Pan Y., Neuss S., Leifert A., Fischler M., Wen F., Simon U., Schmid G., Brandau W., Jahnen-Dechent W. Size-dependent cytotoxicity of gold nanoparticles. Small 2007, 3:1941-1949.
17. Schrand A.M., Bradich-Stolle L.K., Schlager J.J., Dai L., Hussain S.M. Can silver nanoparticles be useful as potential biological labels?. Nanotechnology 2008, 9:1-13.
18. Sheth S.G., Flamm S.L., Gordon F.D., Chopra S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. The American Journal of Gastroenterology 1998, 93:44-48.
19. Takahashi H., Niidome Y., Niidome T., Kaneko K., Kawasaki H., Yamada S. Modification of gold nanorods using phosphatidylcholineto reduce cytotoxicity. Langmuir 2006, 22(1):2-5.
20. De Jong Wim H., Hagens Werner I., Krystek Petra, Burger Marina C., Slips Adriënne J.A.M., Geertsma Robert E. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008, 29:1912-1919.
21. Yu L.E., Yung L.-Y.L., Ong C.-N., Tan Y.-L., Balasubramaniam K.S., Hartono D. Et al. Translocation and effects of gold nanoparticles after inhalation exposure in rats. Nanotoxicology 2007, 1(3):235-242.